JNK-IN-23 (Compound K12) is an inhibitor of JNK. It effectively inhibits the proliferation of MDA-MB-231 cells with a GIC50 of 30 nM. In vivo, JNK-IN-23 blocks metastatic growth of triple-negative breast cancer (TNBC). Additionally, it suppresses the growth of lung metastases by dual targeting of glutaminase-1 (GLS) and the pyruvate dehydrogenase complex (PDHC).
Molecular Weight:
382.5
CAS Number:
[1007786-48-2]
Formula:
C19H18N4OS2
Target:
JNK
T210950
* VAT and and shipping costs not included. Errors and price changes excepted
